OrbiMed Capital GP V LLC
Insider CIK 1615374 · NONE Director, 10% owner · SIBN Director · LOXO Director, 10% owner · DMTX Director, 10% owner · TCDA Director, 10% owner · INSP Director, 10% owner · ADAP Director · CRVS Director, 10% owner · AGLE 10% owner · RYTM 10% owner · NTLA Director · ARMO Director, 10% owner · PMVP Director, 10% owner · ACET Director, 10% owner · NONE Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 40,416 | $6.52 | $263.5K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-08 | 2026-04-09 | 32,523 | $6.29 | $204.6K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 2,400 | $6.38 | $15.3K | 32,523 | SEC↗ |
| ACET Adicet Bio, Inc. | S Sale | 2026-04-07 | 2026-04-09 | 29,319 | $6.53 | $191.5K | 34,923 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2025-10-23 | 2025-10-27 | 1,000,000 | $1.52 | $1.52M | 4,975,291 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 3,500,000 | $1.00 | $3.50M | 4,490,254 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2025-10-08 | 2025-10-10 | 1,500,000 | $1.00 | $1.50M | 9,026,359 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 500,000 | $1.80 | $900.0K | 5,975,291 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | X Exercise deriv | 2025-06-27 | 2025-07-01 | 1,397,684 | — | $0 | 0 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | X Exercise | 2025-06-27 | 2025-07-01 | 1,397,684 | $3.50 | $4.89M | 8,341,338 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | S Sale | 2025-06-27 | 2025-07-01 | 1,176,332 | $4.16 | $4.89M | 7,165,006 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy deriv | 2024-05-06 | 2024-05-08 | 1,444,085 | $1.73 | $2.50M | 1,444,085 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy deriv | 2024-05-06 | 2024-05-08 | 1,397,684 | — | $0 | 1,397,684 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,841,100 | $2.40 | $4.42M | 7,526,359 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 1,041,700 | $2.40 | $2.50M | 1,255,985 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2024-01-25 | 2024-01-26 | 242,200 | $2.40 | $581.3K | 990,254 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2023-11-22 | 2023-11-24 | 87,786 | $2.23 | $195.8K | 0 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 125,000 | $2.09 | $261.2K | 1,027,885 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 250,000 | $2.09 | $522.5K | 646,657 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 442,000 | $2.09 | $923.8K | 5,685,259 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2023-06-27 | 2023-06-29 | 58,000 | $2.09 | $121.2K | 748,054 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-25 | 2022-11-25 | 3,629,226 | $0.22 | $798.4K | 0 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-23 | 2022-11-25 | 5,617,300 | $0.21 | $1.18M | 3,629,226 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2022-11-22 | 2022-11-25 | 1,034,421 | $0.22 | $227.6K | 9,246,526 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-11-08 | 2022-11-10 | 402,000 | $3.21 | $1.29M | 15,219,994 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-05-26 | 2022-05-31 | 26,253 | $15.93 | $418.2K | 87,786 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-13 | 2022-05-13 | 30,722 | $2.49 | $76.5K | 14,817,994 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 97,094 | $2.35 | $228.2K | 14,787,272 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-11 | 2022-05-13 | 64,700 | $1.79 | $115.8K | 14,690,178 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-10 | 2022-05-10 | 24,447 | $1.60 | $39.1K | 14,625,478 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-09 | 2022-05-10 | 90,712 | $1.56 | $141.5K | 14,601,031 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2022-05-06 | 2022-05-10 | 10,200 | $1.63 | $16.6K | 14,510,319 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-31 | 2022-03-31 | 34,500 | $21.17 | $730.4K | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-30 | 2022-03-31 | 75,000 | $22.39 | $1.68M | 34,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-29 | 2022-03-31 | 365,000 | $21.52 | $7.85M | 109,500 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-12-10 | 2021-12-14 | 214,285 | $14.00 | $3.00M | 242,285 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-11-15 | 2021-11-17 | 666,667 | — | $0 | 666,667 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-11-15 | 2021-11-17 | 666,667 | $6.00 | $4.00M | 10,280,947 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2021-11-04 | 2021-11-08 | 3,571,428 | $3.50 | $12.50M | 3,571,428 | SEC↗ |
| CMPX Compass Therapeutics, Inc. | P Buy | 2021-11-04 | 2021-11-08 | 1,785,715 | $3.50 | $6.25M | 14,500,119 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | S Sale | 2021-09-20 | 2021-09-22 | 1,109,644 | $6.09 | $6.76M | 6,943,654 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2021-02-17 | 2021-02-19 | 1,285,714 | $3.50 | $4.50M | 8,053,298 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 420,299 | $13.00 | $5.46M | 5,243,259 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2021-02-12 | 2021-02-18 | 104,050 | $13.00 | $1.35M | 396,657 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | X Exercise deriv | 2020-12-08 | 2020-12-10 | 21,400 | — | $0 | 0 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | S Sale | 2020-12-08 | 2020-12-10 | 21,400 | $1.96 | $41.9K | 0 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | X Exercise | 2020-12-08 | 2020-12-10 | 21,400 | $0.96 | $20.5K | 21,400 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 114,039 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 380,133 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 518,191 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 1,076,891 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 4,025,076 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 380,133 | — | $0 | 6,475,291 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 518,191 | — | $0 | 6,095,158 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 4,025,076 | — | $0 | 4,500,076 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 114,039 | — | $0 | 114,039 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 1,076,891 | — | $0 | 5,576,967 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 475,000 | $18.00 | $8.55M | 475,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 475,000 | $18.00 | $8.55M | 475,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award deriv | 2020-09-17 | 2020-09-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 292,607 | — | $0 | 292,607 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 902,885 | — | $0 | 902,855 | SEC↗ |
| ACET Adicet Bio, Inc. | A Award | 2020-09-15 | 2020-09-17 | 4,822,960 | — | $0 | 4,822,960 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-18 | 2020-08-19 | 43,543 | $108.54 | $4.73M | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-17 | 2020-08-19 | 94,900 | $107.49 | $10.20M | 43,543 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-14 | 2020-08-14 | 20,257 | $109.03 | $2.21M | 138,443 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-13 | 2020-08-14 | 29,251 | $109.93 | $3.22M | 158,500 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-12 | 2020-08-14 | 42,679 | $107.45 | $4.59M | 187,751 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-11 | 2020-08-11 | 39,877 | $105.78 | $4.22M | 230,430 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-10 | 2020-08-11 | 47,700 | $105.23 | $5.02M | 270,307 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-08-07 | 2020-08-11 | 28,993 | $106.18 | $3.08M | 318,007 | SEC↗ |
| NONE Compass Therapeutics, Inc. | P Buy | 2020-06-19 | 2020-06-23 | 1,455,132 | $5.00 | $7.28M | 12,714,404 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-03-06 | 2020-03-10 | 500,000 | $83.52 | $41.76M | 347,000 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-03-03 | 2020-03-05 | 400,000 | $84.42 | $33.77M | 847,000 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-03-03 | 2020-03-05 | 25,000 | $84.55 | $2.11M | 1,247,000 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2020-03-03 | 2020-03-05 | 75,000 | $83.21 | $6.24M | 1,272,000 | SEC↗ |
| TCDA Tricida, Inc. | S Sale | 2019-12-11 | 2019-12-12 | 1,500,000 | $40.00 | $60.00M | 9,614,280 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-11-27 | 2019-11-29 | 47,981 | $71.67 | $3.44M | 1,350,632 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-11-27 | 2019-11-29 | 2,306 | $72.13 | $166.3K | 1,348,326 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-11-27 | 2019-11-29 | 3,100 | $70.60 | $218.9K | 1,398,613 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-11-26 | 2019-11-29 | 20,135 | $69.55 | $1.40M | 1,452,191 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-11-26 | 2019-11-29 | 50,478 | $70.16 | $3.54M | 1,401,713 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-08-06 | 2019-08-08 | 142,656 | $3.51 | $500.7K | 6,767,584 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-07-01 | 2019-07-01 | 59,243 | $3.91 | $231.6K | 6,624,928 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-28 | 2019-07-01 | 565,178 | $3.72 | $2.10M | 6,565,685 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2019-06-27 | 2019-07-01 | 32,923 | $3.34 | $110.0K | 6,000,507 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2019-04-03 | 2019-04-05 | 225,000 | $36.00 | $8.10M | 11,114,280 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-03-08 | 2019-03-11 | 290,231 | $57.75 | $16.76M | 1,471,725 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2019-03-07 | 2019-03-11 | 68,218 | $55.01 | $3.75M | 1,761,956 | SEC↗ |
| INSP Inspire Medical Systems, I | S Sale | 2018-12-11 | 2018-12-13 | 614,772 | $37.60 | $23.12M | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 572,326 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion deriv | 2018-10-19 | 2018-10-19 | 179,404 | — | $0 | 0 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 605,964 | — | $0 | 605,964 | SEC↗ |
| SIBN SI-BONE, Inc. | C Conversion | 2018-10-19 | 2018-10-19 | 179,404 | — | $0 | 785,368 | SEC↗ |
| SIBN SI-BONE, Inc. | P Buy | 2018-10-19 | 2018-10-19 | 200,000 | $15.00 | $3.00M | 985,368 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 17,117,085 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 6,207,674 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 4,255,319 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion deriv | 2018-07-02 | 2018-07-02 | 14,292,958 | — | $0 | 0 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 368,421 | $19.00 | $7.00M | 10,889,280 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,069,175 | — | $0 | 10,520,859 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 3,591,194 | — | $0 | 9,451,684 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 1,559,716 | — | $0 | 1,559,716 | SEC↗ |
| TCDA Tricida, Inc. | C Conversion | 2018-07-02 | 2018-07-02 | 4,300,774 | — | $0 | 5,860,490 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-06-28 | 2018-07-02 | 777,500 | $3.85 | $2.99M | 5,193,946 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 3,709,356 | $50.00 | $185.47M | 3,709,356 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | U Tender | 2018-06-22 | 2018-06-22 | 409,547 | $50.00 | $20.48M | 409,547 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-06-06 | 2018-06-06 | 1,600 | $13.49 | $21.6K | 4,901,310 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-06-04 | 2018-06-06 | 17,100 | $13.57 | $232.0K | 4,902,910 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-06-01 | 2018-06-01 | 50,000 | $13.49 | $674.5K | 4,920,010 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-05-30 | 2018-06-01 | 121,000 | $13.52 | $1.64M | 4,970,010 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-05-22 | 2018-05-24 | 17,980 | $30.38 | $546.2K | 2,751,679 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-05-22 | 2018-05-24 | 1,600 | $30.96 | $49.5K | 2,750,079 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-05-21 | 2018-05-21 | 62,500 | $31.01 | $1.94M | 2,769,659 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2018-05-18 | 2018-05-21 | 69,136 | $30.77 | $2.13M | 2,832,159 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-05-14 | 2018-05-16 | 10,300 | $13.50 | $139.1K | 5,091,010 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 9,160,305 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion deriv | 2018-05-07 | 2018-05-09 | 3,649,635 | — | $0 | 0 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 1,582,904 | — | $0 | 1,582,904 | SEC↗ |
| INSP Inspire Medical Systems, I | C Conversion | 2018-05-07 | 2018-05-09 | 548,817 | — | $0 | 2,131,721 | SEC↗ |
| INSP Inspire Medical Systems, I | P Buy | 2018-05-07 | 2018-05-09 | 312,500 | $16.00 | $5.00M | 2,444,221 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-03-29 | 2018-03-29 | 31,983 | $11.53 | $368.8K | 5,101,310 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2018-03-27 | 2018-03-29 | 1,016,084 | $11.50 | $11.68M | 5,133,293 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2018-03-12 | 2018-03-14 | 588,235 | $8.50 | $5.00M | 5,967,584 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,783,704 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,226,156 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 415,869 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 283,627 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 332,271 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 45,961 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion deriv | 2018-01-30 | 2018-01-30 | 31,315 | — | $0 | 0 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 409,547 | — | $0 | 409,547 | SEC↗ |
| ARMO ARMO BioSciences, Inc. | C Conversion | 2018-01-30 | 2018-01-30 | 3,709,356 | — | $0 | 3,709,356 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-12-08 | 2017-12-12 | 250,000 | $82.50 | $20.63M | 941,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-22 | 2017-11-27 | 267,000 | $75.00 | $20.02M | 1,191,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 100,045 | $74.49 | $7.45M | 1,537,975 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 71,598 | $75.37 | $5.40M | 1,466,377 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 8,377 | $76.23 | $638.6K | 1,458,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 43,300 | $73.48 | $3.18M | 1,638,020 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-16 | 2017-11-20 | 46,680 | $72.46 | $3.38M | 1,681,320 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion deriv | 2017-10-10 | 2017-10-10 | 2,546,295 | — | $0 | 0 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | P Buy | 2017-10-10 | 2017-10-10 | 355,000 | $17.00 | $6.04M | 2,901,295 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | C Conversion | 2017-10-10 | 2017-10-10 | 2,546,295 | — | $0 | 2,546,295 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2017-03-27 | 2017-03-28 | 1,190,476 | $4.20 | $5.00M | 6,149,377 | SEC↗ |
| NONE Aerpio Pharmaceuticals, In | P Buy | 2017-03-15 | 2017-03-17 | 762,995 | $5.00 | $3.81M | 4,416,446 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-21 | 2017-02-21 | 7,000 | $5.36 | $37.5K | 1,469,524 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-17 | 2017-02-21 | 71,800 | $5.19 | $372.6K | 1,462,524 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2017-02-16 | 2017-02-21 | 30,500 | $5.04 | $153.7K | 1,390,724 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-08-10 | 2016-08-12 | 447,857 | $26.96 | $12.07M | 1,728,000 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-24 | 2016-06-27 | 900 | $12.99 | $11.7K | 5,379,349 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-23 | 2016-06-27 | 100 | $12.92 | $1.3K | 5,378,449 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-21 | 2016-06-21 | 26,083 | $12.87 | $335.7K | 5,378,349 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-17 | 2016-06-21 | 12,300 | $12.48 | $153.5K | 5,352,266 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-16 | 2016-06-16 | 5,000 | $12.04 | $60.2K | 5,339,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-15 | 2016-06-16 | 5,000 | $11.94 | $59.7K | 5,334,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-14 | 2016-06-16 | 10,000 | $12.71 | $127.1K | 5,329,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-10 | 2016-06-13 | 20,000 | $12.98 | $259.6K | 5,319,966 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-06-09 | 2016-06-13 | 30,000 | $12.95 | $388.5K | 5,299,966 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-24 | 2016-05-25 | 518,400 | $10.48 | $5.43M | 29,753,404 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-23 | 2016-05-25 | 1,191,600 | $10.40 | $12.39M | 29,235,004 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-20 | 2016-05-24 | 4,716 | $13.09 | $61.7K | 5,269,966 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2016-05-20 | 2016-05-25 | 2,400 | $10.04 | $24.1K | 28,043,404 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-19 | 2016-05-20 | 61 | $12.75 | $778 | 5,265,250 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-19 | 2016-05-20 | 2,539 | $12.11 | $30.7K | 5,265,189 | SEC↗ |
| CRVS Corvus Pharmaceuticals, In | P Buy | 2016-05-18 | 2016-05-20 | 4,200 | $11.55 | $48.5K | 5,262,650 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-13 | 2,857,143 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-13 | 873,475 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2016-05-11 | 2016-05-13 | 191,466 | $18.00 | $3.45M | 2,603,646 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-13 | 1,847,400 | — | $0 | 1,847,400 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-13 | 564,780 | — | $0 | 2,412,180 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | P Buy | 2016-05-11 | 2016-05-13 | 58,534 | $18.00 | $1.05M | 2,662,180 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion deriv | 2015-10-27 | 2015-10-29 | 5,692,874 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion deriv | 2015-10-27 | 2015-10-29 | 9,500,000 | — | $0 | 0 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion | 2015-10-27 | 2015-10-29 | 3,250,085 | — | $0 | 3,250,085 | SEC↗ |
| DMTX Dimension Therapeutics, In | P Buy | 2015-10-27 | 2015-10-29 | 200,000 | $13.00 | $2.60M | 5,397,698 | SEC↗ |
| DMTX Dimension Therapeutics, In | C Conversion | 2015-10-27 | 2015-10-29 | 1,947,613 | — | $0 | 5,197,698 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 337,973 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 1,562,499 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2014-08-06 | 2014-08-06 | 275,385 | $13.00 | $3.58M | 2,175,857 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 1,562,499 | — | $0 | 1,562,499 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2014-08-06 | 2014-08-06 | 337,973 | — | $0 | 1,900,472 | SEC↗ |